Exendin-4 improves long-term potentiation and neuronal dendritic growth in vivo and in vitro obesity condition

Abstract Metabolic syndrome, which increases the risk of obesity and type 2 diabetes has emerged as a significant issue worldwide. Recent studies have highlighted the relationship between metabolic imbalance and neurological pathologies such as memory loss. Glucagon-like peptide 1 (GLP-1) secreted f...

Full description

Bibliographic Details
Main Authors: Ming Wang, Gwangho Yoon, Juhyun Song, Jihoon Jo
Format: Article
Language:English
Published: Nature Portfolio 2021-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-87809-4
_version_ 1818424835958636544
author Ming Wang
Gwangho Yoon
Juhyun Song
Jihoon Jo
author_facet Ming Wang
Gwangho Yoon
Juhyun Song
Jihoon Jo
author_sort Ming Wang
collection DOAJ
description Abstract Metabolic syndrome, which increases the risk of obesity and type 2 diabetes has emerged as a significant issue worldwide. Recent studies have highlighted the relationship between metabolic imbalance and neurological pathologies such as memory loss. Glucagon-like peptide 1 (GLP-1) secreted from gut L-cells and specific brain nuclei plays multiple roles including regulation of insulin sensitivity, inflammation and synaptic plasticity. Although GLP-1 and GLP-1 receptor agonists appear to have neuroprotective function, the specific mechanism of their action in brain remains unclear. We investigated whether exendin-4, as a GLP-1RA, improves cognitive function and brain insulin resistance in metabolic-imbalanced mice fed a high-fat diet. Considering the result of electrophysiological experiments, exendin-4 inhibits the reduction of long term potentiation (LTP) in high fat diet mouse brain. Further, we identified the neuroprotective effect of exendin-4 in primary cultured hippocampal and cortical neurons in in vitro metabolic imbalanced condition. Our results showed the improvement of IRS-1 phosphorylation, neuronal complexity, and the mature of dendritic spine shape by exendin-4 treatment in metabolic imbalanced in vitro condition. Here, we provides significant evidences on the effect of exendin-4 on synaptic plasticity, long-term potentiation, and neural structure. We suggest that GLP-1 is important to treat neuropathology caused by metabolic syndrome.
first_indexed 2024-12-14T14:04:22Z
format Article
id doaj.art-d943b03039be4c6d9379d30b950d4ed8
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T14:04:22Z
publishDate 2021-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-d943b03039be4c6d9379d30b950d4ed82022-12-21T22:58:37ZengNature PortfolioScientific Reports2045-23222021-04-0111111410.1038/s41598-021-87809-4Exendin-4 improves long-term potentiation and neuronal dendritic growth in vivo and in vitro obesity conditionMing Wang0Gwangho Yoon1Juhyun Song2Jihoon Jo3BioMedical Sciences Graduate Program (BMSGP), Chonnam National UniversityBioMedical Sciences Graduate Program (BMSGP), Chonnam National UniversityBioMedical Sciences Graduate Program (BMSGP), Chonnam National UniversityBioMedical Sciences Graduate Program (BMSGP), Chonnam National UniversityAbstract Metabolic syndrome, which increases the risk of obesity and type 2 diabetes has emerged as a significant issue worldwide. Recent studies have highlighted the relationship between metabolic imbalance and neurological pathologies such as memory loss. Glucagon-like peptide 1 (GLP-1) secreted from gut L-cells and specific brain nuclei plays multiple roles including regulation of insulin sensitivity, inflammation and synaptic plasticity. Although GLP-1 and GLP-1 receptor agonists appear to have neuroprotective function, the specific mechanism of their action in brain remains unclear. We investigated whether exendin-4, as a GLP-1RA, improves cognitive function and brain insulin resistance in metabolic-imbalanced mice fed a high-fat diet. Considering the result of electrophysiological experiments, exendin-4 inhibits the reduction of long term potentiation (LTP) in high fat diet mouse brain. Further, we identified the neuroprotective effect of exendin-4 in primary cultured hippocampal and cortical neurons in in vitro metabolic imbalanced condition. Our results showed the improvement of IRS-1 phosphorylation, neuronal complexity, and the mature of dendritic spine shape by exendin-4 treatment in metabolic imbalanced in vitro condition. Here, we provides significant evidences on the effect of exendin-4 on synaptic plasticity, long-term potentiation, and neural structure. We suggest that GLP-1 is important to treat neuropathology caused by metabolic syndrome.https://doi.org/10.1038/s41598-021-87809-4
spellingShingle Ming Wang
Gwangho Yoon
Juhyun Song
Jihoon Jo
Exendin-4 improves long-term potentiation and neuronal dendritic growth in vivo and in vitro obesity condition
Scientific Reports
title Exendin-4 improves long-term potentiation and neuronal dendritic growth in vivo and in vitro obesity condition
title_full Exendin-4 improves long-term potentiation and neuronal dendritic growth in vivo and in vitro obesity condition
title_fullStr Exendin-4 improves long-term potentiation and neuronal dendritic growth in vivo and in vitro obesity condition
title_full_unstemmed Exendin-4 improves long-term potentiation and neuronal dendritic growth in vivo and in vitro obesity condition
title_short Exendin-4 improves long-term potentiation and neuronal dendritic growth in vivo and in vitro obesity condition
title_sort exendin 4 improves long term potentiation and neuronal dendritic growth in vivo and in vitro obesity condition
url https://doi.org/10.1038/s41598-021-87809-4
work_keys_str_mv AT mingwang exendin4improveslongtermpotentiationandneuronaldendriticgrowthinvivoandinvitroobesitycondition
AT gwanghoyoon exendin4improveslongtermpotentiationandneuronaldendriticgrowthinvivoandinvitroobesitycondition
AT juhyunsong exendin4improveslongtermpotentiationandneuronaldendriticgrowthinvivoandinvitroobesitycondition
AT jihoonjo exendin4improveslongtermpotentiationandneuronaldendriticgrowthinvivoandinvitroobesitycondition